Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Point mutations in the presenilin-1 gene (PS1) are a major cause of familial Alzheimer's disease. They result in a selective increase in the production of the amyloidogenic peptide amyloid-beta(1-42) by proteolytic processing of the amyloid precursor protein (APP). Here we investigate whether PS1 is also involved in normal APP processing in neuronal cultures derived from PS1-deficient mouse embryos. Cleavage by alpha- and beta-secretase of the extracellular domain of APP was not affected by the absence of PS1, whereas cleavage by gamma-secretase of the transmembrane domain of APP was prevented, causing carboxyl-terminal fragments of APP to accumulate and a fivefold drop in the production of amyloid peptide. Pulse-chase experiments indicated that PS1 deficiency specifically decreased the turnover of the membrane-associated fragments of APP. As in the regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor, PS1 appears to facilitate a proteolytic activity that cleaves the integral membrane domain of APP. Our results indicate that mutations in PS1 that manifest clinically cause a gain of function and that inhibition of PS1 activity is a potential target for anti-amyloidogenic therapy in Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ is produced by sequential β- and γ-secretase proteolytic cleavage of the amyloid precursor protein (APP) [11–17].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [13]
In the citing paper
“The three major APOE variants, APOE2, APOE3, and APOE4, differ from each other at two amino acid positions, 112 and 158, and modulate AD risk. E3 is the most common APOE variant and is considered neutral with regards to AD risk, while E4 alleles elevate AD risk and E2 reduces AD risk12,13.”
From APOE3 - R136S mutation confers resilience against tau pathology via cGAS-STING-IFN inhibition (2024) · cites this paper as [12]
In the citing paper
“knocking out the gene results in decreased production of both βA4(1-40) and (1-42) amyloid peptides (De Strooper et al. 1998).”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
In the citing paper
“Mutations of presenilin 1 (PS1) causing Alzheimer's disease selectively increase the secretion of the amyloidogenic βA4(1-42)”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
In the citing paper
“As β- (and α-) clipping was virtually normal in neurons derived from those animals, the effect on APP processing is confined to γ-secretase activities (De Strooper et al. 1998).”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834 · cited 1×
“As in the regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription facto”
BackgroundScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921 · cited 1×
“This was confirmed using antibodies against amino-acid residues 595–612 (R1736”
MethodAmyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271
Skeletal and CNS Defects in Presenilin-1-Deficient Mice
Shen, J., Bronson, R. T., Chen, D. F., Xia, W., Selkoe, D. J., & Tonegawa, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80244-5 · Cited by 959
Presenilin 1 is required for Notch 1 and Dll1 expression in the paraxial mesoderm
Wong, P. C., Zheng, H., Chen, H., Becher, M. W., Sirinathsinghji, D. J. S., Trumbauer, M. E., Chen, H. Y., Price, D. L., Van der Ploeg, L. H. T., & Sisodia, S. S. (1997) · Nature · doi:10.1038/387288a0 · Cited by 711
Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides
Hartmann, T., Bieger, S. C., Brühl, B., Tienari, P. J., Ida, N., Allsop, D., Roberts, G. W., Masters, C. L., Dotti, C. G., Unsicker, K., et al. (1997) · Nature Medicine · doi:10.1038/nm0997-1016 · Cited by 709
Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide
Haass, C., & Selkoe, D. J. (1993) · Cell · doi:10.1016/0092-8674(93)90312-e · Cited by 686
Cited by
Items 501–600 of 1,008
Sawmiller, D., Habib, A., Li, S., Darlington, D., Hou, H., Tian, J., Shytle, R. D., Smith, A., Giunta, B., Mori, T., et al. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.08.018 · Cited by 91
“Intracellularly, β-CTF is then cleaved by a multi-protein γ-secretase complex that results in generation of the Aβ peptide and a smaller γ-CTF, also known as C57 (De Strooper et al., 1998; Steiner et al., 1999).”
BackgroundThal, D. R., & Tomé, S. O. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.10.006 · Cited by 84
Activation of the Notch pathway in Down syndrome: cross-talk of Notch and APP
Fischer, D. F. (2005) · The FASEB Journal · doi:10.1096/fj.04-3395.com · Cited by 92
“Notch signaling involves cleavage by -secretase (3, 4), the same proteolytic activity that is required for processing of APP (5, 6).”
BackgroundZhao, G., Liu, Z., Ilagan, M. X. G., & Kopan, R. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3826-09.2010 · Cited by 88
“…strong evidence that -secretase is a multiprotein complex comprised of presenilin (PS; either PS1 or PS2), which contains the catalytic site (De Strooper et al., 1998; Wolfe et al., 1999; Li et al., 2000); nicastrin (NCT), which is thought to contain a substrate binding site (Shah et al.,…”
Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by α- and γ-secretases
Schulte, A., Schulz, B., Andrzejewski, M. G., Hundhausen, C., Mletzko, S., Achilles, J., Reiss, K., Paliga, K., Weber, C., John, S. R., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.100 · Cited by 104
Tomita, T., Watabiki, T., Takikawa, R., Morohashi, Y., Takasugi, N., Kopan, R., De Strooper, B., & Iwatsubo, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011152200 · Cited by 91
Effects of SEL-12 presenilin on LIN-12 localization and function in Caenorhabditis elegans
Levitan, D., & Greenwald, I. (1998) · Development · doi:10.1242/dev.125.18.3599 · Cited by 92
Calcium channelopathies and Alzheimer's disease: Insight into therapeutic success and failures
Chakroborty, S., & Stutzmann, G. E. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.11.012 · Cited by 91
Age-related changes of Alzheimer’s disease-associated proteins in cynomolgus monkey brains
Kimura, N., Tanemura, K., Nakamura, S.-I., Takashima, A., Ono, F., Sakakibara, I., Ishii, Y., Kyuwa, S., & Yoshikawa, Y. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.012 · Cited by 99
Investigating Wnt signaling: a chemogenomic safari
McMillan, M., & Kahn, M. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03613-5 · Cited by 96
An overview of the genes and biomarkers in Alzheimer’s disease
Krishnamurthy, H. K., Jayaraman, V., Krishna, K., Wang, T., Bei, K., Changalath, C., & Rajasekaran, J. J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102599 · Cited by 99
Solans, A., Estivill, X., & de la Luna, S. (2000) · Cytogenetic and Genome Research · doi:10.1159/000015608 · Cited by 86
“Presenilin 1 (PS1) could be the Á-secretase, since mice deficient in PS1 show a decrease in Aß accumulation (De Strooper et al., 1998).”
BackgroundPS1 N- and C-terminal fragments form a complex that functions in APP processing and Notch signaling
Levitan, D. J., Lee, J., Song, L., Manning, R., Wong, G., Parker, E. M., & Zhang, L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211321898 · Cited by 104
Roles for Proteolysis and Trafficking in Notch Maturation and Signal Transduction
Chan, Y.-M., & Jan, Y. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81583-4 · Cited by 101
“8, 771–774.ratio of Ab42 to Ab40, as do presenilin 1 knockout mice (De Strooper et al., 1998).”
BackgroundTranscriptional regulation of Alzheimer's disease genes: implications for susceptibility
Theuns, J. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.16.2383 · Cited by 87
Mutant Presenilin 2 Transgenic Mice
Sawamura, N., Morishima-Kawashima, M., Waki, H., Kobayashi, K., Kuramochi, T., Frosch, M. P., Ding, K., Ito, M., Kim, T.-W., Tanzi, R. E., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004308200 · Cited by 87
Steiner, H., Revesz, T., Neumann, M., Romig, H., Grim, M. G., Pesold, B., Kretzschmar, H. A., Hardy, J., Holton, J. L., Baumeister, R., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007183200 · Cited by 85
Clipping or Extracting: Two Ways to Membrane Protein Degradation
Avci, D., & Lemberg, M. K. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.07.003 · Cited by 92
“Aspartate intramembrane proteases comprise presenilin and SPP-type enzymes and contain two catalytic aspartate residues in the center of adjacent TM helices [42,100,101].”
BackgroundX11α and X11β Interact with Presenilin-1 via Their PDZ Domains
Lau, K., McLoughlin, D. M., Standen, C. L., & Miller, C. C. J. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0898 · Cited by 96
Building γ-secretase – the bits and pieces
Spasic, D., & Annaert, W. (2008) · Journal of Cell Science · doi:10.1242/jcs.015255 · Cited by 84
“These four integral membrane proteins form a functional -secretase complex in which PSs provide the catalytic aspartyl residues (De Strooper et al., 1998; Wolfe et al., 1999).”
BackgroundSelf-citationTachida, Y., Nakagawa, K., Saito, T., Saido, T. C., Honda, T., Saito, Y., Murayama, S., Endo, T., Sakaguchi, G., Kato, A., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05127.x · Cited by 86
“(2008) 104, 1387–1393 1387 Strooper et al. 1998; Wolfe et al. 1999).”
γ-Secretase in biology and medicine
Wolfe, M. S. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.12.011 · Cited by 96
Trafficking, a key player in regulated intramembrane proteolysis
Sannerud, R., & Annaert, W. G. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.11.004 · Cited by 94
Self-citationγ-Protocadherins, Presenilin-mediated Release of C-terminal Fragment Promotes Locus Expression
Hambsch, B., Grinevich, V., Seeburg, P. H., & Schwarz, M. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414359200 · Cited by 85
γ-Secretase as a Target for Alzheimer’s Disease
Wolfe, M. S. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00004-0 · Cited by 96
Dissociated phenotypes in presenilin transgenic mice define functionally distinct γ-secretases
Mastrangelo, P., Mathews, P. M., Chishti, M. A., Schmidt, S. D., Gu, Y., Yang, J., Mazzella, M. J., Coomaraswamy, J., Horne, P., Strome, B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500940102 · Cited by 84
γ-Secretase Catalyzes Sequential Cleavages of the AβPP Transmembrane Domain
Xu, X. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0957 · Cited by 84
“Subsequently, the discovery that genetic knockout of both PS1 and PS2 resulted in total inactivation of γ-secretase activity suggests that presenilin may be functional γ-secretase [51–53].”
Signature Amyloid β Profiles Are Produced by Different γ-Secretase Complexes
Acx, H., Chávez-Gutiérrez, L., Serneels, L., Lismont, S., Benurwar, M., Elad, N., & De Strooper, B. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.530907 · Cited by 77
“However, PSEN1 type -secretase complexes seem to produce most of the A in the CNS (28), whereas PSEN2 complexes have a minor contribution (29).”
BackgroundThe Impact of Cholesterol, DHA, and Sphingolipids on Alzheimer’s Disease
Grimm, M. O. W., Zimmer, V. C., Lehmann, J., Grimm, H. S., & Hartmann, T. (2013) · BioMed Research International · doi:10.1155/2013/814390 · Cited by 80
“Furthermore, a potential contribution to the formation of dendritic and synaptic structures as well as in long-term potentiation (LTP) [6–8] suggests a possible impact on cognitive function.”
BackgroundNeuronal Calcium Signaling and Alzheimer’s Disease
Woods, N. K., & Padmanabhan, J. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2888-2_54 · Cited by 95
Tang, B. L. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.1.7254 · Cited by 83
Gu, F., Zhu, M., Shi, J., Hu, Y., & Zhao, Z. Y. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.050 · Cited by 91
Aleksis, R., Oleskovs, F., Jaudzems, K., Pahnke, J., & Biverstål, H. (2017) · Biochimie · doi:10.1016/j.biochi.2017.07.011 · Cited by 93
Omar, S. H., Scott, C. J., Hamlin, A. S., & Obied, H. K. (2018) · Fitoterapia · doi:10.1016/j.fitote.2018.05.011 · Cited by 79
Landman, N., & Kim, T. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.04.001 · Cited by 93
“[57] showed that PS1 deficiency in knock-out mouse neurons lead to”
BackgroundThe β‐Amyloid Precursor Protein (APP) and Alzheimer's Disease: Does the Tail Wag the Dog?
Koo, E. H. (2002) · Traffic · doi:10.1034/j.1600-0854.2002.31101.x · Cited by 83
“This enigmatic intramembrane cleavage event, also termed regulated intramembrane proteolysis (RIP), has been designated as g-secretase activity and requires the presence of presenilins, either PS1 or PS2, and at least one other obligate member, nicastrin, to form the active g-secretase complex (13,14).”
BackgroundSeparation of presenilin function in amyloid β-peptide generation and endoproteolysis of Notch
Kulic, L., Walter, J., Multhaup, G., Teplow, D. B., Baumeister, R., Romig, H., Capell, A., Steiner, H., & Haass, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100049897 · Cited by 85
Endogenous Presenilin-1 Targets to Endocytic Rather Than Biosynthetic Compartments
Lah, J. J., & Levey, A. I. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0861 · Cited by 84
Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer’s disease
Hamaguchi, T., Ono, K., & Yamada, M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5599-9 · Cited by 89
Guo, Y., Livne‐Bar, I., Zhou, L., & Boulianne, G. L. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-19-08435.1999 · Cited by 89
“Current models suggest that presenilins may directly cause cleavage of Notch and APP or, alternatively, affect the ability of secretases to cleave (De Strooper et al., 1998).”
Pharmacological Knock-down of the Presenilin 1 Heterodimer by a Novel γ-Secretase Inhibitor
Beher, D., Wrigley, J. D. J., Nadin, A., Evin, G., Masters, C. L., Harrison, T., Castro, J. L., & Shearman, M. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103075200 · Cited by 86
Sialylation enhances the secretion of neurotoxic amyloid‐β peptides
Nakagawa, K., Kitazume, S., Oka, R., Maruyama, K., Saido, T. C., Sato, Y., Endo, T., & Hashimoto, Y. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03595.x · Cited by 83
“CTFb is subsequently cleaved by a second protease (c-secretase) to yield Ab and CTFc, and this pathway is known as the b-cleavage pathway (De Strooper et al. 1998; Wolfe et al. 1999).”
BackgroundTen Challenges of the Amyloid Hypothesis of Alzheimer’s Disease
Kepp, K. P. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160550 · Cited by 81
Mori, T., Koyama, N., Yokoo, T., Segawa, T., Maeda, M., Sawmiller, D., Tan, J., & Town, T. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012330 · Cited by 77
“In the amyloidogenic pathway, APP is internalized into endocytic compartments and cleaved by β- and γ-secretases to generate Aβ species (Aβ40 and Aβ42), which then form oligomeric and multimeric aggregates that are neurotoxic (40-43).”
BackgroundAutophagy in axonal degeneration in glaucomatous optic neuropathy
Munemasa, Y., & Kitaoka, Y. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.03.002 · Cited by 84
Lee, J.-H., Lau, K.-F., Perkinton, M. S., Standen, C. L., Shemilt, S. J. A., Mercken, L., Cooper, J. D., McLoughlin, D. M., & Miller, C. C. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300503200 · Cited by 86
Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer’s disease
Epis, R., Marcello, E. E., Gardoni, F., Vastagh, C., Malinverno, M., Balducci, C., Colombo, A. V., Borroni, B., Vara, H., Dell’Agli, M., et al. (2010) · Brain · doi:10.1093/brain/awq217 · Cited by 93
“Ab derives from the concerted action of b–secretase (Vassar et al., 1999), which mediates amyloid precursor protein shedding at Ab N-terminus and g-secretase, responsible for amyloid precursor protein C-terminal stub cleavage (De Strooper et al., 1998).”
Therapeutic role of rifampicin in Alzheimer's disease
Yulug, B., Hanoglu, L., Ozansoy, M., Isık, D., Kilic, U., Kilic, E., & Schabitz, W. R. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12637 · Cited by 81
Lead-Induced Endoplasmic Reticulum (ER) Stress Responses in the Nervous System
Qian, Y., & Tiffany‐Castiglioni, E. (2003) · Neurochemical Research · doi:10.1023/a:1021664632393 · Cited by 86
Intramembrane proteolysis by presenilin and presenilin-like proteases
Xia, W., & Wolfe, M. S. (2003) · Journal of Cell Science · doi:10.1242/jcs.00651 · Cited by 82
Arumugam, T. V., Cheng, Y., Choi, Y., Choi, Y., Yang, S.-H., Yun, Y., Park, J., Yang, D. K., Thundyil, J., Gelderblom, M., et al. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.071076 · Cited by 84
“23 at A SPE T Journals on A ugust 9, 2017 m olpharm .aspetjournals.org swamy et al., 2009), with presenilin being an aspartyl protease that is the catalytic subunit (De Strooper et al., 1998).”
BackgroundNelson, O., Supnet, C., Liu, H., & Bezprozvanny, I. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100159 · Cited by 79
“Consistent with the role of PSs as the catalytic subunits of γ-secretase [5,11,12], FAD mutations in PSs alter AβPP processing to increase the production of the fibrillogenic Aβ42 fragment, a finding consistent with the “amyloid hypothesis” of AD pathogenesis [1, 2].”
Presenilin-1 Regulates Neural Progenitor Cell Differentiation in the Adult Brain
Gadadhar, A., Marr, R., & Lazarov, O. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4767-10.2011 · Cited by 81
Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease
Jones, L., Harold, D. H., & Williams, J. H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.04.005 · Cited by 91
Westlund, B., Parry, D., Clover, R., Basson, M., & Johnson, C. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2497 · Cited by 82
Caselli, R. J., Beach, T. G., Knopman, D. S., & Graff-Radford, N. R. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.02.011 · Cited by 81
Ho, A., Liu, X., & Südhof, T. C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2481-08.2008 · Cited by 69
“The APP-CTF is composed of a short extracellular stub, transmembrane region, and cytoplasmic tail, which subsequently is digested by -secretase within the transmembrane region (De Strooper et al., 1998; Struhl and Adachi, 2000; Yu et al., 2001).”
BackgroundFunctional O-GlcNAc modifications: Implications in molecular regulation and pathophysiology
Vaidyanathan, K., Durning, S. P., & Wells, L. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2014.884535 · Cited by 83
“Active g-secretase is a complex containing four protein subunits, including nicastrin (NCT) required for substrate recognition and binding (De Strooper, 2005, De Strooper et al., 1998).”
BackgroundGuix, F. X., Wahle, T., Vennekens, K., Snellinx, A., Chávez‐Gutiérrez, L., Ill‐Raga, G., Ramos‐Fernandez, E., Guardia‐Laguarta, C., Lleó, A., Arimon, M., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200243 · Cited by 78
“Indeed A b shows heterogeneity, a large part generated at its carboxy-terminus by g -secretase cleavage (De Strooper et al, 1998, reviewed in De Strooper, 2010).”
Phosphorylated Presenilin 1 decreases β-amyloid by facilitating autophagosome–lysosome fusion
Bustos, V., Pulina, M. V., Bispo, A., Lam, A., Flajolet, M., Gorelick, F. S., & Greengard, P. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705240114 · Cited by 79
Human BACE Forms Dimers and Colocalizes with APP
Schmechel, A., Strauss, M., Schlicksupp, A., Pipkorn, R., Haass, C., Bayer, T. A., & Multhaup, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402785200 · Cited by 79
Berezovska, O., Jack, C., Deng, A., Gastineau, N., Rebeck, G. W., & Hyman, B. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008268200 · Cited by 82
Molecular genetics of Alzheimerʼs disease: the role of β-amyloid and the presenilins
Tandon, A., Rogaeva, E., Mullan, M., & St George-Hyslop, P. H. (2000) · Current Opinion in Neurology · doi:10.1097/00019052-200008000-00003 · Cited by 80
The Ubiquitin System in Alzheimer’s Disease
Harris, L. D., Jasem, S., & Licchesi, J. D. F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_8 · Cited by 85
Presenilin/γ-Secretase Regulates Neurexin Processing at Synapses
Saura, C. A., Servián-Morilla, E., & Scholl, F. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019430 · Cited by 79
“generation, as well as the processing of other PS/c-secretase substrates, such as Notch and N-cadherin [27,39,42–44].”
BackgroundIn Vivo Cleavage of α2,6-Sialyltransferase by Alzheimer β-Secretase
Kitazume, S., Nakagawa, K., Oka, R., Tachida, Y., Ogawa, K., Luo, Y., Citron, M., Shitara, H., Taya, C., Yonekawa, H., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409417200 · Cited by 79
Wang, L., Rahn, J. J., Lun, X., Sun, B., Kelly, J. J. P., Weiss, S., Robbins, S. M., Forsyth, P. A., & Senger, D. L. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060289 · Cited by 76
“c-secretase is known to mediate the proteolytic processing of several transmembrane proteins [52,53,55,57–61].”
BackgroundPartial loss of presenilins causes seborrheic keratosis and autoimmune disease in mice
Tournoy, J. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh151 · Cited by 79
“1 is similar to the previously documented antiserum B 10/4 (7) kindly provided by Dr Wim Annaert.”
BackgroundInfluentialSelf-citationAllosteric Modulation of PS1/γ-Secretase Conformation Correlates with Amyloid β42/40 Ratio
Uemura, K., Lill, C. M., Li, X., Peters, J. A., Ivanov, A., Fan, Z., DeStrooper, B., Bacskai, B. J., Hyman, B. T., & Berezovska, O. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007893 · Cited by 75
The amyloid precursor protein of Alzheimer disease in human brain and blood
Li, Q.-X., Fuller, S. J., Beyreuther, K., & Masters, C. L. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.4.567 · Cited by 77
“be components of the g-secretase complex [20, 21].”
Semagacestat Is a Pseudo-Inhibitor of γ-Secretase
Tagami, S., Yanagida, K., Kodama, T. S., Takami, M., Mizuta, N., Oyama, H., Nishitomi, K., Chiu, Y.-W., Okamoto, T., Ikeuchi, T., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.032 · Cited by 74
Tomita, T., Tokuhiro, S., Hashimoto, T., Aiba, K., Saido, T. C., Maruyama, K., & Iwatsubo, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.33.21153 · Cited by 78
Nishiyama, K., Trapp, B. D., Ikezu, T., Ransohoff, R. M., Tomita, T., Iwatsubo, T., Kanazawa, I., Hsiao, K. K., Lisanti, M. P., & Okamoto, T. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-15-06538.1999 · Cited by 78
Complex regulation of γ-secretase: from obligatory to modulatory subunits
Gertsik, N., Chiu, D., & Li, Y.-M. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00342 · Cited by 68
Lessard, C. B., Lussier, M. P., Cayouette, S., Bourque, G., & Boulay, G. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.09.005 · Cited by 87
Function and Dysfunction of the Presenilins
Sisodia, S. S., Kim, S. H., & Thinakaran, G. (1999) · The American Journal of Human Genetics · doi:10.1086/302475 · Cited by 76
HIV-1 Tat Interacts with and Regulates the Localization and Processing of Amyloid Precursor Protein
Kim, J., Yoon, J.-H., & Kim, Y.-S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077972 · Cited by 74
Rogers, K., Felsenstein, K. M., Hrdlicka, L., Tu, Z., Albayya, F., Lee, W., Hopp, S., Miller, M.-J., Spaulding, D., Yang, Z., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-61 · Cited by 75
“the γ-secretase substrates [15,19,29-33].”
ResultSu, Q., Li, T., He, P.-F., Lu, X.-C., Yu, Q., Gao, Q.-C., Wang, Z.-J., Wu, M.-N., Yang, D., & Qi, J.-S. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00746-8 · Cited by 75
“duced from the sequential cleavage of amyloid precursor protein (APP) by β-secretase and γ-secretase [5, 6].”
BackgroundDing, Y., Qiao, A., & Fan, G.-H. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.022 · Cited by 75
“Aβ peptides are generated by successive proteolysis of APP, a large transmembrane glycoprotein that is initially cleaved by the β-site APP-cleaving enzyme 1 (BACE1) and subsequently by γ-secretase in the transmembrane domain (De Strooper et al., 1998; Vassar et al., 1999; Edbauer et al., 2003).”
GSK-3α/β kinases and amyloid production in vivo
Jaworski, T., Dewachter, I., Lechat, B., Gees, M., Kremer, A., Demedts, D., Borghgraef, P., Devijver, H., Kügler, S., Patel, S., et al. (2011) · Nature · doi:10.1038/nature10615 · Cited by 79
Protease Regulation: The Yin and Yang of Neural Development and Disease
Bai, G., & Pfaff, S. L. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.012 · Cited by 86
“…cleavage cascade within the cell membrane (Parks and Curtis, 2007). g-secretase is known to have dozens of substrates, but two of the better known are Notch and amyloid precursor protein (APP) (Figures 3A and 3B and Table 1) (De Strooper et al., 1998; Mumm and Kopan, 2000; Parks and Curtis, 2007).”
Wild-type Presenilin 1 Protects against Alzheimer Disease Mutation-induced Amyloid Pathology
Wang, R., Wang, B., He, W., & Zheng, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512574200 · Cited by 73
Pastorcic, M., & Das, H. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005411200 · Cited by 58
Gudey, S. K., Sundar, R., Mu, Y., Wallenius, A., Zang, G., Bergh, A., Heldin, C.-H., & Landström, M. (2014) · Science Signaling · doi:10.1126/scisignal.2004207 · Cited by 74
“Presenilin 1 (PS1) is a transmembrane protein that is the catalytic subunit of the g-secretase complex (14, 15).”
BackgroundHasegawa, M. (2016) · Biomolecules · doi:10.3390/biom6020024 · Cited by 72
“The discovery of AD-related mutations in presenilin 1 and 2 [6–8], which are catalytic subunits of the γ-secretase complex involved in APP cleavage and Aβ production [9–11], further supported the hypothesis.”
ResultImplication of APP Secretases in Notch Signaling
Hartmann, D., Tournoy, J., Säftig, P., Annaert, W. G., & Strooper, B. D. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:171 · Cited by 76
“This refers to the processing of a heterogenous group of transmembrane proteins, in vertebrates currently encompassing APP (De Strooper et al., 1998), IRE1 (Niwa et al., 1999, but see Sato et al., 2000 for an opposing view) and ATF6 (Ye et al., 2000), the SREBPs (Sakai et al., 1998), and the notch…”
BackgroundSelf-citationChen, F., Yang, D.-S., Petanceska, S., Yang, A., Tandon, A., Yu, G., Rozmahel, R., Ghiso, J., Nishimura, M., Zhang, D. M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006986200 · Cited by 75
Saura, C. A., Tomita, T., Davenport, F., Harris, C. L., Iwatsubo, T., & Thinakaran, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.13818 · Cited by 75
Presenilin-1 adopts pathogenic conformation in normal aging and in sporadic Alzheimer’s disease
Wahlster, L., Arimon, M., Nasser-Ghodsi, N., Post, K. L., Serrano-Pozo, A., Uemura, K., & Berezovska, O. (2013) · Acta Neuropathologica · doi:10.1007/s00401-012-1065-6 · Cited by 71
“The catalytic subunit of the c-secretase enzyme complex is a 467 amino acid protein with nine-transmembrane domains named presenilin-1 (PS1) [13, 72].”
Kim, J. W., Kim, M., Kim, K. J., Yun, H. J., Chae, J. S., Hwang, S. G., Chang, T.-S., Park, H.-S., Lee, K.-W., Han, P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501600102 · Cited by 77
Kirschenbaum, F., Hsu, S.-C., Cordell, B., & McCarthy, J. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004697200 · Cited by 72
A Role for Presenilin 1 in Regulating the Delivery of Amyloid Precursor Protein to the Cell Surface
Leem, J. Y., Saura, C. A., Pietrzik, C., Christianson, J., Wanamaker, C., King, L. T., Veselits, M. L., Tomita, T., Gasparini, L., Iwatsubo, T., et al. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0546 · Cited by 72
“Recent genetic and biochemical evidence closely links PS1 and PS2 to a protease activity, termed -secretase, which generates the COOH-terminus of A (De Strooper et al., 1998; Naruse et al., 1998; Wolfe et al., 1999).”
BackgroundAmyloid precursor protein-induced axonopathies are independent of amyloid-β peptides
Stokin, G. B., Almenar-Queralt, A., Gunawardena, S., Rodrigues, E. M., Falzone, T., Kim, J., Lillo, C., Mount, S. L., Roberts, E. A., McGowan, E., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn240 · Cited by 78
Tolia, A., Horré, K., & De Strooper, B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802461200 · Cited by 69
Transcriptional regulation and its misregulation in Alzheimer’s disease
Chen, X.-F., Zhang, Y.-W., Xu, H., & Bu, G. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-44 · Cited by 67
“catalytic subunits of γ-secretase [104-106].”
Li, J., Pauley, A. M., Myers, R. L., Shuang, R., Brashler, J. R., Yan, R., Buhl, A. E., Ruble, C., & Gurney, M. E. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01105.x · Cited by 72
“They have been shown to be essential for the gammacleavage of APP (De Strooper et al. 1998) and have been thought to contain the active site for c-secretase and suggested to be part of a complex with c-secretase activity (Wolfe et al. 1999; Esler et al. 2000; Li et al. 2000a,b; Seiffert et al.…”
BackgroundNovel Class of Polytopic Proteins with Domains Associated with Putative Protease Activity
Grigorenko, A. P., Moliaka, Y., Коровайцева, Г. И., & Rogaev, E. I. (2002) · Biochemistry (Moscow) · doi:10.1023/a:1016365227942 · Cited by 77
Tani, M., Iida, H., & Ito, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207932200 · Cited by 72
A molecular clock involved in Somite segmentation
Maroto, M., & Pourquié, O. (2001) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(01)51007-8 · Cited by 79
Metadata
- Authors
- De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- University of Göttingen (DE)
- Venue
- Nature
- Published
- 1998-01
- Volume
- 391
- Issue
- 6665
- Pages
- 387-390
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1655404681
- Cited by
- 1,818
- References
- 30
- Citations by year
- 2026: 19 · 2025: 39 · 2024: 47 · 2023: 42 · 2022: 33 · 2021: 35 · 2020: 53 · 2019: 43 · 2018: 36 · 2017: 58 · 2016: 60 · 2015: 43 · 2014: 55 · 2013: 64 · 2012: 71
- FWCI
- 76.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- presenilin 1, amyloid precursor protein, APP processing, gamma-secretase, amyloid-beta 42, Alzheimer's disease, familial Alzheimer's disease, carboxyl-terminal fragment, gain-of-function, membrane proteolysis
- MeSH terms
- Animals, Cells, Cultured, Humans, Membrane Proteins, Neurons, Peptide Fragments, Endopeptidases, Protein Processing, Post-Translational, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, Amyloid beta-Protein Precursor, Point Mutation, Mice, Presenilin-1, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.